Barclays PLC Biogen Inc. Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	BUY	$189.07 - $236.8 $1.74 Million - $2.18 Million	9,200 Added 68.15%	22,700 $4.4 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $2.06 Million - $2.56 Million	10,800 Added 400.0%	13,500 $3.13 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $13.6 Million - $17.2 Million	-64,300 Reduced 95.97%	2,700 $582,000
Q4 2023 Feb 15, 2024	SELL	$222.59 - $267.94 $14.1 Million - $17 Million	-63,400 Reduced 48.62%	67,000 $17.3 Million
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $26.9 Million - $30.4 Million	106,200 Added 438.84%	130,400 $33.5 Million
Q2 2023 Aug 03, 2023	SELL	$275.25 - $318.06 $7.46 Million - $8.62 Million	-27,100 Reduced 52.83%	24,200 $6.89 Million
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $34.8 Million - $39.6 Million	-135,500 Reduced 72.54%	51,300 $14.3 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $47.2 Million - $57.3 Million	186,800 New	186,800 $51.7 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $22.8 Million - $27.1 Million	121,700 Added 213.51%	178,700 $36.4 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $12.7 Million - $16.4 Million	56,900 Added 56900.0%	57,000 $13.7 Million
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $7.07 Million - $9.23 Million	-25,000 Reduced 99.6%	100 $28,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $1.3 Million - $2.07 Million	5,000 Added 24.88%	25,100 $8.69 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $24.1 Million - $28.3 Million	-99,400 Reduced 83.18%	20,100 $5.62 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $9.17 Million - $13.8 Million	38,800 Added 48.08%	119,500 $29.3 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $14.9 Million - $17.2 Million	56,100 Added 228.05%	80,700 $22.9 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $19.6 Million - $25.9 Million	-75,700 Reduced 75.47%	24,600 $6.58 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $2.93 Million - $3.72 Million	-10,900 Reduced 9.8%	100,300 $31.7 Million
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $4.56 Million - $6.29 Million	20,700 Added 22.87%	111,200 $33 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $521,856 - $585,312	-2,400 Reduced 2.58%	90,500 $21.1 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $3.05 Million - $3.36 Million	-13,900 Reduced 13.01%	92,900 $21.7 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $11.4 Million - $17.9 Million	52,800 Added 97.78%	106,800 $25.2 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $11 Million - $13.9 Million	-39,400 Reduced 42.18%	54,000 $16.3 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $13.9 Million - $18.1 Million	47,200 Added 102.16%	93,400 $33 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $3.79 Million - $4.51 Million	14,700 Added 46.67%	46,200 $13.4 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $24.6 Million - $34.8 Million	-94,700 Reduced 75.04%	31,500 $8.63 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $12.3 Million - $13.8 Million	-40,100 Reduced 24.11%	126,200 $40.2 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $46.8 Million - $54.8 Million	166,300	166,300 $52.1 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account